Cameco (TSE:CCO – Get Free Report) (NYSE:CCJ) had its price target hoisted by investment analysts at Scotiabank from C$88.00 to C$93.00 in a research note issued to investors on Monday,BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. Scotiabank’s price target suggests a potential upside of 0.49% from the stock’s current price.
Several other research analysts also recently weighed in on CCO. Stifel Canada upgraded shares of Cameco to a “strong-buy” rating in a research report on Wednesday, March 12th. National Bankshares increased their target price on Cameco from C$81.00 to C$95.00 in a report on Monday. Sanford C. Bernstein raised Cameco to a “strong-buy” rating in a research note on Tuesday, April 1st. TD Securities increased their price objective on Cameco from C$77.00 to C$100.00 and gave the company a “buy” rating in a research note on Monday. Finally, Raymond James lifted their target price on shares of Cameco from C$83.00 to C$88.00 and gave the stock an “outperform” rating in a research note on Monday. Eight analysts have rated the stock with a buy rating and five have assigned a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Buy” and a consensus target price of C$90.10.
Check Out Our Latest Research Report on Cameco
Cameco Stock Up 11.9%
Cameco Company Profile
Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.
Read More
- Five stocks we like better than Cameco
- Technology Stocks Explained: Here’s What to Know About Tech
- Why Unity Software May Be the AI Breakout No One Saw Coming
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Institutional Investors Couldn’t Resist These 5 Stocks in Q1
- Health Care Stocks Explained: Why You Might Want to Invest
- Which U.S. Towns See Economic Change First? [2025 Survey]
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.